Although rats have been widely used in evaluating various causes of vasculogenic erectile dysfunction (VED), the atherosclerotic rat model has seldom been tried probably due to its inherent tolerance to a cholesterol diet. To enhance endothelial sensitivity to cholesterol diet, we tested the effects of transient interruption of nitric oxide synthase on atherogenesis induced by cholesterol diet in a rat model. Rats with atherosclerosis (AS group) received 1% cholesterol diet for 6 weeks. During the initial 2 weeks, they drank water that contained N G -nitro-L-arginine methyl ester (L-NAME) (3 mg/ml). After 6 weeks, we carried out histologic and hemodynamic evaluation to confirm pelvic atherosclerosis and erectile dysfunction, respectively, and the results were compared with those of cholesterol only (Chol) group and normal control (C) group. Compared to the C or Chol group, the mean intima/media (I/M) of the internal pudendal artery, which contributes approximately 70% of the total resistance of the penile vasculature, was markedly increased by the treatment (1.8270.25 vs 0.7770.13, Po0.05). Correspondingly, significantly diminished erectile function was observed. Combined treatment for 2 weeks elicited early atherosclerotic changes in proximal arteries and erectile impairment and further 4 weeks of cholesterol diet spread overt atherosclerosis to the periphery. The Chol group showed no arterial pathology, although they showed mild VED. A correlation study showed that atherosclerosis of the distal artery was better correlated with erectile dysfunction than the proximal artery. Based on these results, our study demonstrates that combination treatment of cholesterol diet with L-NAME would be used as a rapid, effective protocol of developing atherosclerotic rat model of VED.
Introduction
Atherosclerotic vascular disease is one of the leading causes of vasculogenic erectile dysfunction (VED). 1 In men with VED, it has been demonstrated that obstructing the arterial inflow by atherosclerotic lesions in the hypogastric-cavernous bed is associated with impairment of erectile function. [2] [3] [4] Impaired arterial inflow and secondary cavernosal dysfunction probably due to hypoxia have been proposed as possible mechanisms of atherosclerotic VED. 5 However, recent laboratory and clinical studies have demonstrated that the arterial insufficiency was not the sole determinant of VED. In the case of hypercholesterolemia and diabetes, in vitro study showed impairment of cavernosal smooth muscle relaxation, which is not influenced by decreased arterial inflow. 6, 7 Thus, it appears that arterial insufficiency due to atheromatous plaque is secondary to molecular alterations such as endothelial dysfunction, but we do not have any relevant animal data regarding temporal relationship between the two processes. This may partly be due to the lack of an adequate animal model that enables us to follow the pathologic process in a limited amount of time.
To date, various methods of developing atherosclerosis have been described. [8] [9] [10] Ligation of the pudendal artery and balloon endothelial denudation technique may be inadequate techniques in examining endothelial function. 8, 9 Cholesterol feeding may be the most physiological method in developing atherosclerosis in animals. 10 However, in several species such as monkeys, rabbits, dogs and sheep, cholesterol feeding may require too much time (months or years) to cause pelvic atherosclerosis and it also often leads to severe complications such as stroke, liver dysfunction and cholestatic jaundice. 5 Therefore, we tried to develop a fast, feasible model of VED that may complement the methods described by others.
Male rats offer several advantages. First, male rats show many similarities to behavioral and endocrine aspects of sexual activities in men. Second, the cavernous nerve can easily be identified and the bioassay for erectile function has been validated in the rats. Despite these advantages, there have been limited amounts of studies regarding the rat model of atherosclerotic VED. To our knowledge, there were only two published studies of hypercholesterolemic rats rather than atherosclerosis. 11, 12 Part of the reason may be that rats have been known as 'cholesterol resistant', which is the traditional method of developing atherosclerosis. 13 However, recent study from other vascular beds indicated that a rapid atherosclerotic process could be generated in rats by the chronic, systemic administration of nitric oxide synthase (NOS) inhibitor.
14 So we elected to investigate the feasibility of the rat model of atherosclerosis based on this finding. We hypothesized that adding temporary systemic inhibition of nitric oxide (NO) to the cholesterol diet might generate VED with pelvic atherosclerosis in rats.
To testify our hypothesis, we designed an experiment to examine our new regimen in the rat model and evaluated the effects on pelvic vasculature and cavernosal tissue. If our assumption is right, the model will show significant atherosclerosis in pelvic vasculature and subsequent cavernosal ischemic changes.
Materials and methods

Induction of atherosclerosis in a rat model
Our protocol was approved by the institutional Animal Care and Use Committee at the Seoul National University Hospital. A high cholesterol diet has long been used as a method of eliciting atherosclerosis in an animal model. However, as the rat is known as a cholesterol-resistant animal, the effects of a simple cholesterol diet on the formation of atherosclerosis in rats was not obvious. We initially examined the effects of a 6-week cholesterol diet on physiological parameters, pelvic vasculature and erectile function in six 12-week-old male Sprague-Dawley (SD) rats. After confirmation of the results of the cholesterol-only group (Chol), we decided to test our modified treatment regimen (data will be presented in 'Result', section).
A total of 30 adult 12-weeks-old male SD rats (weighing 250-300 g each) were divided into the control (C, n ¼ 15) and atherosclerosis (AS, n ¼ 15) groups. The C group was placed on a regular diet and the AS group was fed a daily 1% cholesterol diet (CRF-1; Oriental Yeast Co. Ltd, Osaka, Japan) for 6 weeks. We added a 2-week treatment of N G -nitro-Larginine methyl ester (L-NAME, 3 mg/ml) via their drinking water to induce intimal changes that would make them vulnerable to atherosclerosis.
Experimental protocol
To examine whether the 2 weeks of combined treatment would generate early systemic atherosclerotic changes, five rats of the treatment group and five rats of the C group were anesthetized by urethane (1.6 g/kg) and their body weights were measured. Peripheral blood (3 ml) was collected for the determination of cholesterol levels. To monitor continuously the mean systemic arterial pressure (SAP) and intracavernosal pressure (ICP), cannulation of the carotid artery and corpus cavernosum was performed, respectively. Pressure data were collected and analyzed electronically (Powerlabt, ADInstruments, CO, USA).
Erectile response was elicited by electrical stimulation of the cavernous nerve as described previously (6 V, 1 ms, 20 Hz). 15 After determination of the erectile function by cavernous electrostimulation, the animal was killed. A 10% formalin solution was subsequently infused for 15 min at a pressure of 90 mmHg. The aorta just above the level of aortoiliac bifurcation, the internal iliac artery just below the level of iliac bifurcation and the internal pudendal arteries proximal to cavernosum were surgically removed and placed in formalin. All fixed tissue samples were paraffin embedded, mounted on slides and stained by two methods: hematoxylin and eosin staining (H & E) and elastica van Gieson (EVG) staining.
After 6 weeks, the remaining rats (10 rats in the AS group, 10 rats in the C group) underwent the same procedures as described above.
Histomorphometry
For histologic analysis, at least three slides for each arterial level per animal were used. The degree of atherosclerosis was evaluated based on the intima/ media (I/M) ratio. the average of I/M ratios from multiple segments was used to minimize variances caused by anatomical variations. The I/M ratio in A novel rat model of VED K Park et al each segment of the artery was determined by averaging I/M ratios from four positions, as illustrated in Figure 2a .
To evaluate the influence of luminal narrowing on the erectile function, the relationship between the I/M and the ICP/SAP was evaluated by the nonparametric Spearman's correlation analysis.
Statistical analysis
The results are expressed as means7s.d. Physiological, biochemical and morphological data were compared using the parametric Student's t-test and the nonparametric Mann-Whitney test where relevant. The differences were considered significant when the P-values were o0.05.
Results
Changes in arterial pressure, body weight and serum cholesterol
Compared to the C group, both the SAP and mean serum level of cholesterol of the AS group were significantly increased after the initial 2 weeks of treatment. Furthermore, another 4 weeks of the cholesterol diet further aggravated both indices. Like the AS group, the Chol group showed significantly elevated SAP and serum cholesterol but the SAP was higher in the AS group. Treatment of L-NAME or cholesterol did not significantly alter the somatic growth of rats (Table 1) .
Erectile response to cavernous electrostimulation
Typical erectile responses elicited during cavernous electrostimulation of the C and AS groups are displayed in Figure 1 . While the C group showed a rapid increase in ICP that persisted during the stimulation period, both the 2-week-treated rats and 6-week-treated rats showed significant impairment of erectile function as characterized by the prolonged mean time to peak pressure and depressed peak ICP. The Chol group also showed erectile dysfunction similar to 2-week-treated rats. A novel rat model of VED K Park et al
As the SAP was elevated by the treatment, the ICP/ SAP was further diminished by the treatment (Table 2) .
Sequential vascular changes
Compared to the control rats, a 2-week treatment with L-NAME and the 1% cholesterol diet induced early atherosclerotic changes characterized by intimal thickening, widening and focal disruption of the elastic lamella (Figure 2b-d) . Further treatment resulted in the further disorganization of the elastic structure, formation of neointima and luminal narrowing ( Figure 2f) . As a result, the mean I/M of the major arteries was significantly increased with the passage of time. Similar changes also occurred in the peripheral internal pudendal arteries ( Figure 3 ). While the mean I/M was not significantly changed during the 2 weeks of treatment, the ratio was significantly increased after 6 weeks of treatment ( Table 3 ). The 6-week cholesterol diet did not show any discernible effects on pelvic vasculature.
Correlation analysis
To evaluate which site of atherosclerosis is more influential on the erectile impairment, correlation analysis between the I/M and the ICP/SAP was carried out. In all arteries examined, Spearman's correlation coefficient indicated a significant link between the I/M and the ICP/SAP (P ¼ 0.035, 0.001 and 0.006 in the aorta, internal iliac artery and prepenile artery, respectively). The correlation coefficient of the internal pudendal artery, internal iliac artery and aorta was À0.752, À0.611 and À0.585, respectively, revealing the fact that the distally located lesion had a more negative influence on the ICP/SAP than the proximally located lesion.
Discussion
The main finding of our study is that 6 weeks of a cholesterol diet combined with early short-term (2 weeks) NOS inhibition could generate erectile dysfunction associated with pelvic atherosclerosis in rats. Rats have been widely used in evaluating various causes of VED; however, an atherosclerotic rat model has not been tried, probably due to its inherent tolerance to a cholesterol diet. In our study, 6 weeks of cholesterol diet had no impact on arterial pathology, so treatment consisting of simple cholesterol diet appears to be ineffective in eliciting atherosclerotic VED in the rat model. However, given the advantages of rats over other animals in investigating erectile dysfunction, the establishment of a rat model of atherosclerotic VED was expected to facilitate the further understanding of VED. To overcome the tolerance to cholesterol diet, we have modified the previous experimental results that evaluated the effects of chronic inhibition of NO.
In other vascular beds, NO is known to mediate vasorelaxation, inhibit platelet aggregation and promote antiproliferative action, antiadhesive action and antioxidative function and this molecule appears to play a central role in protecting the vascular integrity. 16 Thus, the results of chronic NO inhibition using an NOS inhibitor in an animal model have demonstrated the creation of atherosclerosis in the major vasculature such as the heart and aorta. 14, 16, 17 According to the results from experiments on other vascular beds, a short-term (3-7 days) administration of L-NAME (1 mg/ml) could induce early atherosclerotic changes in the rat coronary artery, but a prolonged administration (4-8 weeks) of L-NAME may produce severe cardiovascular complications such as a stroke and renal damage. 14, 16 Based on these findings, we hypothesized that a modification of these findings may elicit and spread atherosclerotic changes to the pelvic vasculature, which was sufficient in developing VED. We elevated the dose of L-NAME from previously used 1 to 3 mg/ml and prolonged the duration of treatment to 2 weeks. Since a previous study reported early coronary atherosclerotic changes after administration of 1 mg/ml of L-NAME for 1 week, 16 we expected that this intensified regimen might effectively generate early atherosclerotic changes in systemic vasculature. Although the duration of L-NAME treatment may be directly correlated with the degree of atherosclerosis, it was limited to 2 weeks because more than 4 weeks of treatment was reported to increase the incidence of cardiovascular complication and may directly influence the erectile function. Since L-NAME has a relatively short physiologic half-life (6 h), 18 maintaining 4 weeks of off-period of L-NAME treatment may prevent lasting effects of L-NAME from erectile function. Ferraz et al 19 revealed that the male rat sexual response was recovered after 14 days of L-NAME treatment suspension.
Consistent with our hypothesis, 2 week administration of the combination regimen could change the intimal properties, which are characterized by a widening and derangement of the elastic lamina in the pelvic vasculatures. A subsequent cholesterol diet resulted in intimal thickening and luminal narrowing aggravating erectile impairment. We believed that eliciting these intimal changes was the critical step in developing mature atherosclerosis in inherently cholesterol-resistant rats.
Our model gave new experimental evidence regarding the clinical course of atherosclerotic VED. In humans, erectile dysfunction was proposed as the sentinel event of vascular disease; 20 however, the temporal relationship between erectile function and cardiovascular status has not been evaluated in animal study. Consistent with the clinical situation, atherosclerotic changes were clearly preceded by impairment of erection from our study. It was observed that 6 weeks of cholesterol diet or 2 weeks of combined treatment commonly resulted in impairment of erection, although both were not associated with significant atherosclerosis. After 6 weeks of combined treatment, further impairment of erectile function was accomplished by obstructive atherosclerosis. These findings indicated that erectile dysfuncion might precede arterial pathology in early atherosclerosis but progression of atherosclerosis may become important in determining final erectile function. As hypercholesterolemia and L-NAME treatment were often associated with impairment of the endothelium-dependent cavernosal relaxation, the putative mechanism of early VED may be the endothelial dysfunction, which is characterized as the decreased bioavailability of NO. 21 Another advantage of our model is that it is closer to the human disease than any other animal model. The rats showed generalized, distally dominant atherosclerosis rather than a focal, proximal one. In addition, the erectile dysfunction was more correlated with atherosclerosis of distal arteries than proximal arteries.
The limitation of our study should be discussed. As rats revealed multiple pelvic atherosclerosis, they may also have a chance of ischemic changes in the brain and spinal cord and erectile function may be influenced. Undoubtedly, cavernous electrostimulation was not an appropriate test in evaluating central effects of erection, so another method would have to be tried for the assessment of central A novel rat model of VED K Park et al effects. Also, our model made it difficult to evaluate the antierectile effects purely attributed by pelvic atherosclerosis. Elevated blood pressure was noted in the Chol group as well as in the AS group. Like hypercholesterolemia, hypertension is known to mitigate endothelial function by increased vasoconstrictor tone and a defect in endothelium-dependent relaxation activity. 22 However, atherosclerotic VED is mainly dependent on cardiovascular status, and assessment of any therapeutic modality without consideration of vascular effects may be invalid. In this respect, our model may be useful in evaluating cardiovascular effects of a systemically administered proerectile drug such as type 5 phosphodiesterase inhibitor. Furthermore, the model may be used in examining the effects of various cardiovascular drugs on erectile function.
Conclusion
In conclusion, instead of a simple cholesterol diet, we have generated atherosclerosis by combining early short-term treatment of NOS inhibitor, which enhanced early atherosclerotic changes, with conventional cholesterol diet in the rat model. The treated rats showed generalized atherosclerosis and erectile dysfunction, which was close to human pathology.
